VeIP regimen: Difference between revisions
No edit summary |
No edit summary |
||
Line 6: | Line 6: | ||
==Overview== | ==Overview== | ||
{{PAGENAME}} refers to a regimen consisting of [[vinblastine|vinblastine ( | {{PAGENAME}} refers to a regimen consisting of [[vinblastine|vinblastine (velban)]], [[ifosfamide]], [[mesna]] and [[cisplatin|cisplatin (platinol)]] used for the treatment of advanced-stage [[germ cell tumor|germ cell ovarian and testicular cancers]]<ref name="pmid2844110">{{cite journal| author=Loehrer PJ, Lauer R, Roth BJ, Williams SD, Kalasinski LA, Einhorn LH| title=Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide. | journal=Ann Intern Med | year= 1988 | volume= 109 | issue= 7 | pages= 540-6 | pmid=2844110 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2844110 }} </ref> | ||
==Regimen== | ==Regimen== | ||
Line 16: | Line 16: | ||
==Indications== | ==Indications== | ||
*[[germ cell tumor| | *[[germ cell tumor|Germ cell ovarian and testicular cancers]]<ref name="pmid2844110">{{cite journal| author=Loehrer PJ, Lauer R, Roth BJ, Williams SD, Kalasinski LA, Einhorn LH| title=Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide. | journal=Ann Intern Med | year= 1988 | volume= 109 | issue= 7 | pages= 540-6 | pmid=2844110 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=2844110 }} </ref> | ||
==References== | ==References== |
Latest revision as of 13:54, 30 March 2015
WikiDoc Resources for VeIP regimen |
Articles |
---|
Most recent articles on VeIP regimen Most cited articles on VeIP regimen |
Media |
Powerpoint slides on VeIP regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on VeIP regimen at Clinical Trials.gov Clinical Trials on VeIP regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on VeIP regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on VeIP regimen Discussion groups on VeIP regimen Patient Handouts on VeIP regimen Directions to Hospitals Treating VeIP regimen Risk calculators and risk factors for VeIP regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for VeIP regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:VeIP; VeIP Regimen; VeIP regimen; Velban-Ifosfamide-Platinol Regimen
Overview
VeIP regimen refers to a regimen consisting of vinblastine (velban), ifosfamide, mesna and cisplatin (platinol) used for the treatment of advanced-stage germ cell ovarian and testicular cancers[1]
Regimen
VeVinblastine (Velban)
IIfosfamide
PCisplatin (Platinol)
Indications
References
- ↑ 1.0 1.1 Loehrer PJ, Lauer R, Roth BJ, Williams SD, Kalasinski LA, Einhorn LH (1988). "Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide". Ann Intern Med. 109 (7): 540–6. PMID 2844110.